14707-75-6

Usage

Uses

Used in Chemical Reactions:
1,3,5-TRIAZATRICYCLO[3.3.1.1(3,7)]DECAN-7-AMINE is used as a reactant in various chemical reactions due to its unique structure and reactivity. Its tricyclic amine nature allows it to participate in a wide range of chemical transformations, contributing to the synthesis of diverse organic compounds.
Used in Pharmaceutical Industry:
1,3,5-TRIAZATRICYCLO[3.3.1.1(3,7)]DECAN-7-AMINE is used as a building block or intermediate in the synthesis of pharmaceutical compounds. Its heterocyclic amine structure can be incorporated into drug molecules to modulate their biological activity, potentially leading to the development of new therapeutic agents with improved efficacy and selectivity.
Used in Material Science:
1,3,5-TRIAZATRICYCLO[3.3.1.1(3,7)]DECAN-7-AMINE can be utilized in the development of novel materials with specific properties. Its tricyclic amine structure can be employed to design and synthesize new polymers, coatings, or other materials with tailored characteristics for various applications, such as sensors, catalysts, or advanced materials for energy storage and conversion.

Upstream product

• 14612-28-3 7-nitro-1,3,5-triazaadamantane 

Downstream Products

• 52100-95-5 7-Chlor-1,3,5-triazaadamantan 
• 129058-65-7 N-bruneomycinyl-7-amino-1,3,5-triazaadamantane 

Relevant academic research and scientific papers

HETEROADAMANTANES AND THEIR DERIVATIVES. 4. SYNTHESIS OF 1,3,5-TRIAZAADAMANTANE

Reduction of 7-nitro-1,3,5-triazaadamantane with hydrazine hydrate in the presence of Raney nickel gave 7-hydroxyamino- and 7-amino-1,3,5-triazaadamantane, from which 7-chloro-, 7-bromo-, and 7-thiocyanato-1,3,5-triazaadamantanes were synthesized by substitutive deamination.Desulfurization of 7-thiocyanato-1,3,5-triazaadamantane in the presence of Raney nickel gave 1,3,5-triazaadamantane.

COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION

This invention relates with anti-tumor activities of new compounds containing an adamantyl group or analogs thereof. The invention also relates with the medication applications of anti-tumor and other diseases by this kind of compounds with the combination of S, P, T structures containing adamantyl group and the formation of stereoisomer, tautomers, prodrug, pharmaceutically acceptable salts, complex salts or solvates to their anticancer application and anticancer agents, which have the following general formula:

7-(N-Methyl-N-alkylamino)-1,3,5-triazaadamantanes

A series of high-density 7-(N-methyl-N-alkylamino)-1,3,5 triazaadamantanesre prepared. The preparation involves first adding the alkyl group to the parent amine by reacting the amine with a suitable aldehyde and hydrogen in the presence of a platinum catalyst and then reacting the thus produced secondary amine with formaldehyde and hydrogen in the presence of a nickel catalyst to produce the final product. The series represents a new class of fuels which is particularly useful in volume-limited applications.